Western blot of COL4A2 (P175) pAb in extracts from Jurkat cells.
COL4A2 / Collagen IV Alpha2 Antibody (Pro175)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human, Mouse |
| Format: | Liquid |
$328.00each
Catalog Number: LS-C176967-50
Catalog Number: LS-C176967
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Collagen IV Alpha2 antibody LS-C176967 is an unconjugated rabbit polyclonal antibody to Collagen IV Alpha2 (COL4A2) (Pro175) from human. It is reactive with human and mouse. Validated for IF, IHC and WB. Cited in 1 publication.
- Application
- IF, IHC, IHC-P, WB
- Reactivity
- Hu, Ms
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- Canstatin | Collagen alpha-2(IV) chain | Collagen, type IV, alpha 2 | ICH | POREN2 | COL4A2
- UniProt Number
- P08572
- SwissProt
- P08572
Target
- Target
- Human COL4A2 / Collagen IV Alpha2
- Antigen Species
- Hu
- Epitope
- Human COL4A2
- Gene Name
- COL4A2
Antibody
- Host Species
- Rb
- Clonality
- Polyclonal
Immunogen
- Immunogen
- Synthetic peptide around Pro175 of human COL4A2
- Immunogen Type
- SP-Lin
Format
- Conjugate/Label
- Unconj
- Format
- Liquid
- Formulation
- PBS, pH 7.2, 0.05% Sodium Azide
- Volume
- 50 Microliter
- Preservative
- Yes
- Purification Method
- AP
Storage & Handling
- Storage Conditions
- Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
Defining the Extracellular Matrix of Rhabdomyosarcoma. Xiaolei Lian, J Steffan Bond, Narendra Bharathy, Sergei P Boudko, Elena Pokidysheva, Jack F Shern, Melvin Lathara, Takako Sasaki, Teagan Settelmeyer, Megan M Cleary, Ayeza Bajwa, Ganapati Srinivasa, Christopher P Hartley, Hans Peter Bächinger, Atiya Mansoor, Sakir H Gultekin, Noah E Berlow, Charles Keller. Frontiers in oncology. 2021 March;11:601957. PubMed: 33708626 PMC: PMC7942227